Brief: MAIA Biotechnology Reports First Quarter 2023 Financial Results
08/05/2023 13:04
May 8 (Reuters) - Maia Biotechnology Inc MAIA.A :
* MAIA BIOTECHNOLOGY REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* MAIA BIOTECHNOLOGY INC - HAD CASH TOTALING APPROXIMATELY
$7.6
MILLION AS OF MARCH 31, 2023
Source text for Eikon: ID:nBw8ZSWKCa
Further company coverage: MAIA.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale